Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Badimon

Showing results (91-100 of 262) with videos related to

Pageof 27
Sort By:
Circulation Research|October 1, 1992
Cod liver oil alters platelet-arterial wall response to injury in pigsJ Y Lam, J J Badimon, R D Ellefson, et al.
Journal of Cardiovascular Pharmacology|January 11, 2020
Direct Oral Anticoagulants and Coronary Artery Disease: The Debacle of the Aspirin Era?Álvaro García-Ropero, Ariana P Vargas-Delgado, Carlos G Santos-Gallego, et al.
Current Molecular Medicine|August 22, 2006
The role of high-density lipoprotein cholesterol in the prevention and possible treatment of cardiovascular diseasesB G Choi, G Vilahur, D Yadegar, et al.
Blood|July 15, 1991
Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelationL Badimon, J J Badimon, R Lassila, et al.
Annals of Medicine|November 16, 2019
HDL therapy today: from atherosclerosis, to stent compatibility to heart failureC R Sirtori, M Ruscica, L Calabresi, et al.
Thrombosis and Haemostasis|September 6, 2003
Membrane-associated CD40L and sCD40L in atherothrombotic diseaseSunil X Anand, Juan F Viles-Gonzalez, Juan J Badimon, et al.
Journal of Cardiovascular Pharmacology|April 9, 2004
Tissue factor coagulation pathway: a new therapeutic target in atherothrombosisJuan F Viles-Gonzalez, Sunil X Anand, M Urooj Zafar, et al.
Circulation|June 1, 1991
Importance of experimental models for the development of clinical trials on thromboatherosclerosisV Fuster, J H Ip, L Badimon, et al.
Journal of the American College of Cardiology|December 1, 1992
Echocardiographic "smoke" is produced by an interaction of erythrocytes and plasma proteins modulated by shear forcesA Merino, P Hauptman, L Badimon, et al.
Thrombosis Research|July 19, 2000
Comparative study of antithrombotic effect of a low molecular weight heparin and unfractionated heparin in an ex vivo model of deep arterial injuryM Roqué, U Rauch, E D Reis, et al.
Pageof 27

Showing results (91-100 of 262) with videos related to

Sort By:
Pageof 27
Circulation Research|October 1, 1992
Cod liver oil alters platelet-arterial wall response to injury in pigsJ Y Lam, J J Badimon, R D Ellefson, et al.
Journal of Cardiovascular Pharmacology|January 11, 2020
Direct Oral Anticoagulants and Coronary Artery Disease: The Debacle of the Aspirin Era?Álvaro García-Ropero, Ariana P Vargas-Delgado, Carlos G Santos-Gallego, et al.
Current Molecular Medicine|August 22, 2006
The role of high-density lipoprotein cholesterol in the prevention and possible treatment of cardiovascular diseasesB G Choi, G Vilahur, D Yadegar, et al.
Blood|July 15, 1991
Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelationL Badimon, J J Badimon, R Lassila, et al.
Annals of Medicine|November 16, 2019
HDL therapy today: from atherosclerosis, to stent compatibility to heart failureC R Sirtori, M Ruscica, L Calabresi, et al.
Thrombosis and Haemostasis|September 6, 2003
Membrane-associated CD40L and sCD40L in atherothrombotic diseaseSunil X Anand, Juan F Viles-Gonzalez, Juan J Badimon, et al.
Journal of Cardiovascular Pharmacology|April 9, 2004
Tissue factor coagulation pathway: a new therapeutic target in atherothrombosisJuan F Viles-Gonzalez, Sunil X Anand, M Urooj Zafar, et al.
Circulation|June 1, 1991
Importance of experimental models for the development of clinical trials on thromboatherosclerosisV Fuster, J H Ip, L Badimon, et al.
Journal of the American College of Cardiology|December 1, 1992
Echocardiographic "smoke" is produced by an interaction of erythrocytes and plasma proteins modulated by shear forcesA Merino, P Hauptman, L Badimon, et al.
Thrombosis Research|July 19, 2000
Comparative study of antithrombotic effect of a low molecular weight heparin and unfractionated heparin in an ex vivo model of deep arterial injuryM Roqué, U Rauch, E D Reis, et al.
Pageof 27